We are live on ! Find out more
SGYP

Synergy Pharmaceuticals
SGYP

Delisted

SGYP was delisted on the 7th of March, 2019.

80 hedge funds and large institutions have $142M invested in Synergy Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 35 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 6

119% more call options, than puts

Call options by funds: $1.55M | Put options by funds: $709K

103% more capital inflows, than outflows

Capital inflows: $21.6M | Capital outflows: $10.6M

11% more funds holding

Funds holding: 72 → 80 (+8)

2.46% more ownership

Funds ownership: 26.42% → 28.88% (+2.5%)

11% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 35

Holders
80
Holders Change
+8
Holders Change %
+11.11%
% of All Funds
2.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
31
Reduced
35
Closed
6
Calls
$1.55M
Puts
$709K
Net Calls
+$844K
Net Calls Change
+$249K

SGYP Hedge Fund Activity: Q1 2014 in Review

80 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals (SGYP) for Q1 2014, worth a combined $142M — up 2.2% from $139M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new SGYP positions and 6 closed out — a net gain of 8 holders — while 31 added to existing stakes and 35 trimmed.

The largest buyer was State Street, adding an estimated $11.4M. The largest seller was Baker Bros. Advisors, cutting an estimated $4.97M.

  • 80 institutional investors held Synergy Pharmaceuticals (SGYP) as of Q1 2014, up from 72 in Q4 2013.
  • Funds reported $142M of Synergy Pharmaceuticals stock for Q1 2014, up 2.2% quarter-over-quarter.
  • 14 funds opened new Synergy Pharmaceuticals positions in Q1 2014 and 6 closed out, a net change of +8 holders.
  • The largest Synergy Pharmaceuticals buyer in Q1 2014 was State Street, an estimated $11.4M added.
  • The largest Synergy Pharmaceuticals seller in Q1 2014 was Baker Bros. Advisors, an estimated $4.97M sold.

Based on aggregated 13F filings for Q1 2014.